SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales declined to Rs. 35810.00 millions for the March 2023 quarter as compared to Rs. 43260.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2023 is Rs. -1630.00 millions as compared to Net Profit of Rs. 7030.00 millions of corresponding quarter ended March 2022Operating Profit reported a sharp decline to 2290.00 millions from 10470.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 35810.00 43260.00 -17.22 187830.00 164490.00 14.19 187830.00 164490.00 14.19
Other Income 720.00 5810.00 -87.61 4620.00 6310.00 -26.78 4620.00 6310.00 -26.78
PBIDT 2290.00 10470.00 -78.13 27460.00 26880.00 2.16 27460.00 26880.00 2.16
Interest 1200.00 980.00 22.45 4990.00 3770.00 32.36 4990.00 3770.00 32.36
PBDT 1090.00 9490.00 -88.51 22350.00 23050.00 -3.04 22350.00 23050.00 -3.04
Depreciation 1650.00 2750.00 -40.00 9510.00 10440.00 -8.91 9510.00 10440.00 -8.91
PBT -560.00 6740.00 -108.31 12840.00 12610.00 1.82 12840.00 12610.00 1.82
TAX 1070.00 -290.00 -468.97 3090.00 850.00 263.53 3090.00 850.00 263.53
Deferred Tax 50.00 -1600.00 -103.13 -50.00 -1350.00 -96.30 -50.00 -1350.00 -96.30
PAT -1630.00 7030.00 -123.19 9750.00 11760.00 -17.09 9750.00 11760.00 -17.09
Equity 1500.00 1530.00 -1.96 1500.00 1530.00 -1.96 1500.00 1530.00 -1.96
PBIDTM(%) 6.39 24.20 -73.58 14.62 16.34 -10.54 14.62 16.34 -10.54

UPL Share Price

660.95 -4.05 (-0.61%)
20-Apr-2026 09:43 View Price Chart
Peers
Company Name CMP
UPL 660.95
PI Industries 3114.00
Bayer CropScience 4883.45
Sharda Cropchem 1107.15
Sumitomo Chemical 430.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×